Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
Starday Foods is a healthy and sustainable food products company.
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Cephagenix focuses on identifying and developing new, effective migraine therapies.
Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Accent Therapeutics is a biopharmaceutical company.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
AbbVie has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
AbbVie's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post-IPO Equity round. AbbVie's total known invested capital is $3.1B.
AbbVie's average investment size is $54.2M across its portfolio of 57 companies.
Recent AbbVie portfolio additions include Quanta Therapeutics, Alector, Cloverleaf Bio, Inventiva Pharma, Endlyz Therapeutics. These companies were founded in 2020 or later.